Merck & Co., Inc. Other Current Liabilities
Merck & Co., Inc. (MRK) had Other Current Liabilities of $14.72 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Other Liabilities, Current $14.72B.
- 2026-03-31: Other Liabilities, Current $14.55B.
- 2025-12-31: Other Liabilities, Current $14.47B.
- 2025-09-30: Other Liabilities, Current $16.19B.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $14.72B 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $14.55B 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $14.47B 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $16.19B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $14.50B 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $12.77B 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $15.69B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $16.54B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $14.71B 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $14.10B 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $15.77B 10-K · filed 2025-02-25 | |
| 2023-09-30 | $14.84B 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $13.75B 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $13.00B 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $14.16B 10-K · filed 2024-02-26 | |
| 2022-09-30 | $14.22B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $13.50B 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $14.05B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $13.86B 10-K · filed 2023-02-24 | |
| 2021-09-30 | $14.21B 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $12.89B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $11.91B 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $12.21B 10-K · filed 2022-02-25 | $13.05B 10-K · filed 2021-02-25 |
| 2020-09-30 | $11.69B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $11.18B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $10.93B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $12.55B 10-K · filed 2021-02-25 | |
| 2019-09-30 | $11.77B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $11.05B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $10.08B 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $10.15B 10-K · filed 2020-02-26 | |
| 2018-09-30 | $9.78B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $9.76B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $9.71B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $10.43B 10-K · filed 2019-02-27 | |
| 2017-09-30 | $9.99B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $9.36B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $8.66B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $10.27B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $9.09B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $9.26B 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $10.04B 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $11.22B 10-K · filed 2017-02-28 | |
| 2015-09-30 | $9.61B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $9.52B 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $9.87B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $10.52B 10-K · filed 2016-02-26 | |
| 2014-09-30 | $9.81B 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $8.83B 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $8.71B 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $9.50B 10-K · filed 2015-02-27 | |
| 2013-09-30 | $9.18B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $8.87B 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $9.57B 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $9.74B 10-K · filed 2014-02-27 | |
| 2012-09-30 | $8.92B 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $8.92B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $8.82B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $10.17B 10-K · filed 2013-02-28 | $9.73B 10-K · filed 2012-02-28 |
| 2011-09-30 | $9.23B 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $8.75B 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $8.51B 10-K · filed 2012-02-28 | |
| 2009-09-30 | $2.00B 10-Q · filed 2009-10-29 | |
| 2009-06-30 | $2.15B 10-Q · filed 2009-07-24 | |
| 2008-12-31 | $2.08B 10-Q · filed 2009-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |